Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Psyence Group Inc (PSYG.CN)

Psyence Group Inc (PSYG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE FOR PALLIATIVE CARE Newswire.ca - Thu Dec 15, 2022

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament"), a clinical-stage natural psychedelic drug development company, and Psyence...

FLHLF : 0.0335 (unch)
PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
The Power Play by The Market Herald Releases New Interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and Empower Clinics AccessWire - Thu Jun 2, 2022

VANCOUVER, BC / ACCESSWIRE / June 2, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and...

AVU.VN : 0.020 (-20.00%)
GDNP.VN : 0.015 (unch)
HANK.VN : 0.050 (-16.67%)
PSYG.CN : 0.0150 (+50.00%)
CBDT.CN : 0.050 (unch)
Psyence Group Corporate Update Globe Newswire - Thu Jun 2, 2022

Highlights: Partnership with CRO Clerkenwell Health to design and deliver Psyence’s UK clinical trial progressing; exclusive licensing agreement with...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence Taps Another Pharma Exec to Drive its Clinical Program Globe Newswire - Tue May 31, 2022

TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Market Movers. Today’s Top Stock Picks For New & Trending Opportunities AccessWire - Fri May 27, 2022

Market Movers. Today's Top Stock Picks For New & Trending Opportunities

BAU.VN : 0.130 (unch)
BAUFF : 0.0750 (-28.50%)
LIT.VN : 0.170 (+3.03%)
PNXLF : 0.2415 (-6.90%)
VEJI.CN : 0.0050 (-50.00%)
VEJIF : 0.0525 (-25.00%)
EWG.CN : 0.1700 (unch)
EWGFF : 0.0001 (-99.80%)
NFTX.NE : 0.3350 (-1.47%)
CRDL.TO : 2.70 (unch)
CRDL : 1.9800 (+3.13%)
AALI.VN : 0.025 (unch)
The Power Play by The Market Herald Releases Interviews With Hank Payments, Red Pine Exploration, Affinor Growers, Nextech AR, Star Navigation, and Psyence AccessWire - Tue Apr 19, 2022

VANCOUVER, BC / ACCESSWIRE / April 19, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Hank Payments, Red Pine Exploration, Affinor Growers, Nextech AR, Star...

FH.NE : 0.0450 (-10.00%)
HANK.VN : 0.050 (-16.67%)
RPX.VN : 0.085 (unch)
AFI.CN : 0.1050 (-12.50%)
NTAR.CN : 0.0750 (unch)
NEXCF : 0.0500 (-6.02%)
SNA.CN : 0.0050 (-50.00%)
PSYG.CN : 0.0150 (+50.00%)
FH : 1.52 (+9.35%)
Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products Globe Newswire - Tue Apr 19, 2022

The partnership leverages Psyence’s expertise in fungi cultivation and palliative care as well as Filament’s expertise in the manufacture of pharmaceutical...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
FILAMENT HEALTH AND PSYENCE ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR NATURAL PSILOCYBIN PRODUCTS Newswire.ca - Tue Apr 19, 2022

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0335 (unch)
PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence Group Announces DTC Eligibility Approval in the U.S. Globe Newswire - Wed Feb 9, 2022

TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (+50.00%)
The Power Play by The Market Herald Releases Interviews With Opawica Explorations, Psyence Group, and C3 Metals AccessWire - Mon Feb 7, 2022

VANCOUVER, BC / ACCESSWIRE / February 7, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Opawica Explorations, Psyence Group, and C3 Metals on their latest news....

OPW.VN : 0.110 (-4.35%)
PSYG.CN : 0.0150 (+50.00%)
CCCM.VN : 0.250 (unch)

Barchart Exclusives

These 3 High-yielding Dividend Aristocrats Are Also Up 10% YTD Barchart - Fri Jul 5, 6:00PM CDT
On the hunt for quality companies with positive price performance? These 3 are up 10% YTD and offer above-average yields. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot